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Fig. S1.  Loss of individual SEAC subunits does not substantially affect the growth of cells at 30°C or 
eIF2α phosphorylation after leucine starvation. (A) Optical density was measured at 600 nm. As expected 
based on their intrinsically low TORC1 activity (Fig. 1C), triple sea2¨ sea3¨ sea4¨ mutant cells 
exhibited a slow growth phenotype (lower panel on the right). Data are means ± S.D. from three 
independent experiments. (B) Phosphorylation of eIF2α (on Ser51; eIF2α-P) was assessed as previously 
described (12) prior to (+) and following  (-) a 60-min period of leucine starvation. One representative 
immunoblot from three independent experiments is shown. 
Fig. S2.  Effects on TORC1 activity of various combinations of individual deletions of SEAC subunit-










terminus of Sch9 were used to quantify TORC1 activity (the ratio of hyperphosphorylated 
[+P]/hypophosphorylated [-P] Sch9) presented in Fig. 1C. 
Fig. S3.  Loss of Iml1-Npr2-Npr3 complex subunits, individually or in combination, or expression of 
Gtr1Q65L or of Iml1R943A renders TORC1 activity partially insensitive to leucine starvation. TORC1 
activities (means + S.D.; n=3 independent experiments, assayed as in Fig. 1A) were assessed following 30 
min of leucine starvation and normalized to the respective value in each strain before leucine starvation. 
***P<0.001, **P<0.01 in Student’s t-test versus wild-type control (P-values are Holm-Bonferroni 
adjusted). 
Fig. S4. Iml1 physically interacts with Gtr1-TAP in the presence, but substantially less in the absence, of 
Npr2 and Npr3. Lysates (Input) from exponentially growing wild-type and npr2¨ npr3¨ cells expressing 
the indicated fusion proteins and TAP pull-down fractions were analyzed by immunoblotting using anti-











Fig. S5.  The conserved residue Arg943 in Iml1 is functionally important. (A) Alanine scanning of 
conserved arginine and glutamine residues in Iml1 indicates that Arg943 is important for the TORC1-
inhibitory activity of overexpressed Iml1-TAP (assayed as in Fig. 1A). One representative immunoblot 
from two independent experiments is shown . (B) Effects of overexpression of Iml1-TAP and Iml1R943A-
TAP on TORC1 activity were assayed in three independent replicates (means + S.D. are shown). Fusion 
protein expression was confirmed by immunoblot analysis (lower panel). ***P<0.001, in Student’s t-test 
(P-values are Holm-Bonferroni adjusted). 
Fig. S6.  Purified Iml1-His6 and Iml1R943A-His6 preferentially bind bacterially expressed GST-Gtr1 
preloaded with GDP plus AlFx. In vitro GST-pulldown experiments were performed with bacterially 
expressed GST-Gtr1 preloaded with GDP alone (+/-) or GDP plus AlFx (+/+) and either purified Iml1-










Table S1.  Strains used in this study 
Strain Genotype Source Figure 
YL515 [BY4741/2]MATα; his3¨1, leu2¨0, ura3¨0 (6) 1A-D; 2A, C; 4C,G; 
S1-3; S5A, B 
YL516 [BY4741/2]MATa; his3¨1, leu2¨0, ura3¨0 (6) 2D 
NP04-4C [YL515] MATα; iml1¨::kanMX4 This study 1A, B, D; 2A; 4G; 
S1; S3; S5A, B 
NP15-1B [YL515] MATα; npr2¨::kanMX4 This study 1A, B, D; 2A; S1; S3 
NP23-4D [YL515] MATα; npr3¨::kanMX4 This study 1A, B, D; 2A; S1; S3 
NP12-1D [YL515] MATα; sea2¨::kanMX4 This study 1A, B; S1 
NP13-7A [YL515] MATα; sea3¨::kanMX4 This study 1A, B; S1 
NP14-3C [YL515] MATα; sea4¨::kanMX4 This study 1A, B; S1 
NP21-1B [YL515] MATα; npr2¨::kanMX4, npr3¨::kanMX4 This study 1C; S2, 3 
MP282-9A [YL515] MATα; iml1¨::kanMX4,npr2¨::kanMX4, 
npr3¨::kanMX4
This study 1C; S1-3 
NP33-2B [YL515] MATα; sea2¨::kanMX4, sea3¨::kanMX4, 
sea4¨::kanMX4
This study 1C; S1, S2 
NP35-9D [YL515] MATα; iml1¨::kanMX4, sea2¨::kanMX4, 
sea3¨::kanMX4, sea4¨::kanMX4
This study 1C; 1F; S2 
NP37-7A [YL516] MATa; npr2¨::kanMX4, sea2¨::kanMX4, 
sea3¨::kanMX4, sea4¨::kanMX4 
This study 1C; S2 
NP38-6B [YL515] MATα; npr3¨::kanMX4, sea2¨::kanMX4, 
sea3¨::kanMX4, sea4¨::kanMX4
This study 1C; S2 
KT1961 MATa; his3, leu2, ura3-52, trp1 (30) 1F 
MP240-1C [KT1961] MATa; iml1¨::kanMX4 This study 1E; 3B 
MP294-8B [KT1961] MATa; iml1¨::kanMX4, npr2¨::kanMX4 This study 1E 
MP295-6B [KT1961] MATa; iml1¨::kanMX4, npr3¨::kanMX4 This study 1E 
MP296-5B [KT1961] MATa; iml1¨::kanMX4, 
npr2¨::kanMX4, npr3¨::kanMX4
This study 1E 
MP285-1A [KT1961] MATa; npr2¨::kanMX4 This study 1E; 3B 
MP287-5B [KT1961] MATa; npr2¨::kanMX4, 
npr3¨::kanMX4
This study 1E 
MP286-1B [KT1961] MATa; npr3¨::kanMX4 This study 1E; 3B 
MP290-2D [KT1961] MATa; ego1¨::kanMX4, 
ego3¨::kanMX4, gtr1¨::natMX4, gtr2¨::natMX4
This study 1E 
MB27 [YL515] MATα; gtr1¨::HIS3 (6) 2A 
MB28 [YL515] MATα; gtr2¨::HIS3 (6) 2A 
MB34 [YL515] MATα; tco89¨::HIS3 (6) 2A 
MP202-1C [YL515] MATα; gtr1¨::HIS3, iml1¨::kanMX4 This study 2A; 3F; 4A, B, E, F; 
S6 










Table S1. Strains used in this study - continued
Strain Genotype Source Figure 
MP203-5A [YL515] MATα; tco89¨::HIS3, iml1¨::kanMX4 This study 2A 
NP17-4H [YL515] MATα; gtr1¨::kanMX4, npr2¨::kanMX4 This study 2A 
NP19-2B [YL515] MATα; gtr1¨::HIS3, npr3¨::kanMX4 This study 2A 
NP03-4B [YL516] MATa; iml1¨::kanMX4 This study 2D 
MB32 [YL516] MATa; gtr1¨::kanMX4 (6) 2D; S3 
MP242-2D [YL516] MATa; MYC-IML1, IGO1-TAP::KanMX4 This study 3A 
MP241-2C [YL516] MATa; MYC-IML1, gtr1¨::HIS3 This study 3A, D; S4 
MP306-16A [YL516] MATa; MYC-IML1, gtr1¨::HIS3, 
npr2¨::kanMX4, npr3¨::kanMX4
This study S4 
MJA351-2A [KT1961] MATa; iml1::IML1-VN-TRP1,  
gtr1::GTR1-VC-HIS3
This study 3C 
MP256-5B [YL515] MATα; kog1::KOG1-HA-KanMX4, 
gtr1¨::HIS3










Table S2.  Plasmids used in this study 
Plasmid Description Source Figure 
pRS413 CEN, HIS3 (31) 1D-F; 2A; 3A, B, 
F; 4A, B, E, F; S1; 
S6 
pRS414 CEN, TRP1 (31) 1E, F; 3B 
pRS415 CEN, LEU2 (31) 1A-C, E, F; 2A-C; 
3A, C; 4C, G; S5A, 
B; S1A, S2; S4 
pRS416 CEN, URA3 (31) 1A-D, G; 2B-D; 
3A, C; 4G: S1-S3; 
S5A, B 
pJU1064 [pRS413] SCH9T570A-HA5 (25) 1A-C, G; 2B-D; 
4G; S2, 3; S5A, B 
pJU1058 [pRS415] SCH9T570A-HA5 (25) 1D 
pJU1030 [pRS416] SCH9T570A-HA5 (25) 2A; 4C 
BG1805 2μ, URA3, GAL1p Open 
Biosystems 
pNP1946 [BG1805] IML1- HIS6 This study 1D; 2C; 4G 
pNP2094 [BG1805] NPR2- HIS6 This study 1D 
pNP2095 [BG1805] NPR3- HIS6 This study 1D 
pNP2106 [BG1805] NPR3- HIS6, ura3::HIS3 This study 1D 
YCplac111 CEN, LEU2 (32)  
pDK2698 [YCplac111] ADH1p-SYO1-(GA)5-3xEGFP (33)  
pDK2712 [YCplac111] ADH1p-3xEGFP-(GA)5-RIX7 D. Kressler  
pMP2118 [YCplac111] IML1p-IML1-(GA)5-3xEGFP, 
leu2::URA3
This study 1E, F; 3B 
pNP2350 [pRS416]  IML1p-IML1-R943A-(GA)5-3xEGFP This study S3 
pFLJ2286 [pRS416] NPR2p-NPR2-(GA)5-3xEGFP This study 1E; 3B 
pFLJ2293 [pRS416] NPR3p-3xEGFP-(GA)5-NPR3 This study 1E; 3B 
pMP2149 [pRS416] CYC1p-HHF2-Tdimer2(12),
ura3::HIS3 
This study 1F 
YCplac33 CEN, URA3 (32)  
pMB1393 [YCplac33] TetON-GTR1 (GTR1-WT) (6) 2B 
pMB1394 [YCplac33] TetON-GTR1Q65L (GTR1-GTP) (6) 2B, D; S3 
pMB1395 [YCplac33] TetON-GTR1S20L (GTR1-GDP) (6) 2B 
pPM1621 [YCplac111] TetON-GTR2 (GTR2-WT) This study 2B 
pPM1622 [YCplac111] TetON-GTR2 Q66L (GTR2-GTP) This study 2B, C 
pPM1623 [YCplac111] TetON-GTR2 S23L (GTR2-GDP) (12) 2B, C 
pPM1397 [YCplac111] TetON-GTR1 Q65L (GTR1-GTP) This study 2C 
pPM1398 [YCplac111] TetON-GTR1 S20L (GTR1-GDP) This study 2C 
pMB1344 [YCplac33] GTR1p-GTR1-TAP (6) 3A, D, E; S4 
pMB1372 [YCplac33] GTR1p-GTR1 Q65L –TAP (6) 3D, E 
pRS425 2μ, LEU2 (34)  
pFLJ2251 [pRS425] GAL1p-IML1 This study 3E 
pJU650 [pRS416] GTR1p-GTR1 R. Loewith 3E; S4 
pDK2261 [YCplac111] NSA1p-NSA1- HIS6-TEV-ProtA D. Kressler  










    
Table S2. Plasmids used in this study - continued
Plasmid Description Source Figure
pNP2055 [YCplac111] ADH1p-IML1- HIS6-TEV-ProtA This study 3F; 4A, B, E, F; 
S5B, S6 
pNP2125 [YCplac111] ADH1p-IML1-R273A- HIS6-TEV-ProtA This study S5A 
pNP2126 [YCplac111] ADH1p-IML1-Q284A- HIS6-TEV-ProtA This study S5A 
pNP2127 [YCplac111] ADH1p-IML1-R519A- HIS6-TEV-ProtA This study S5A 
pNP2128 [YCplac111] ADH1p-IML1-R943A- HIS6-TEV-ProtA This study 4E; S5A, B; S6 
pNP2129 [YCplac111] ADH1p-IML1-R1009A- HIS6-TEV-ProtA This study S5A 
pNP2130 [YCplac111] ADH1p-IML1-R1059A- HIS6-TEV-ProtA This study S5A 
pNP2131 [YCplac111] ADH1p-IML1-R1077A- HIS6-TEV-ProtA This study S5A 
pNP2132 [YCplac111] ADH1p-IML1-R1109A- HIS6-TEV-ProtA This study S5A 
pNP2133 [YCplac111] ADH1p-IML1-R1400A- HIS6-TEV-ProtA This study S5A 
pNP2134 [YCplac111] ADH1p-IML1-R1499A- HIS6-TEV-ProtA This study S5A 
pNP2285 [pRS416] ADH1p-IML1- HIS6-TEV-ProtA This study 4F 
pFLJ1931 [pET-24d] GST-TEV This study 3F; S6 
pNP2035 [pET-24d] GST-TEV-GTR1 This study 3F; 4A, B, D-F; S6 
pNP2038 [pET-24d] GST-TEV-GTR2 This study 4B 
pMP2101 [pGEX-4T] GST-CDC42 This study 4B 
pNP2137 [pET-24d] GST-TEV-IML1GAP(877-1178) This study 4D, E 
pNP2142 [pET-24d] GST-TEV-IML1GAP(877-1178)-R943A This study 4D, E 
pJU1013 [pET-28a] GTR1-LE-HIS6 R. Loewith 4F 
pJU1047 [pGEX-6P] GST-TEV-GTR2 S23L-HIS6 R. Loewith 4F 
pJU1048 [pGEX-6P] GST-TEV-GTR2Q65L-HIS6 R. Loewith 4F 
pRS426 2μ, URA3 (34)  
pFLJ1981 [pRS426] GAL1p-IML1(1-1548) This study 4C 
pFLJ1982 [pRS426] GAL1p-IML1(1-1274) This study 4C 
pFLJ1983 [pRS426] GAL1p-IML1(1-1184) This study 4C 
pFLJ1984 [pRS426] GAL1p-IML1(585-1184) This study 4C 
pFLJ1985 [pRS426] GAL1p-IML1(113-585) This study 4C 
pFLJ1986 [pRS426] GAL1p-IML1(1184-1548) This study 4C 
pFLJ1987 [pRS426] GAL1p-IML1(1284-1548) This study 4C 
YCplac195 2μ, URA3 (32)  
pNP2208 [YCplac195] GAL1p-DEPDC5- HIS6 This study 4G 
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